glp-1 and insulin Agonists: Increasing Effective Release Favorable Effects of GLP-1 Receptor

Today, the FDA is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies including Hims &amp

With Semaglutide patents expiring in 2026, Indian pharma has a chance to lead the GLP-1 drug market.

Josh Eloge joins the show to explain how medications like Ozempic and Wegovy may impact anxiety, depression, and overall brain chemistry

In the case that we present, the patient stopped duraglutide abruptly due to lack of insurance coverage and regained the weight she had lost within a month

Avoid injecting right after a heavy meal

Get insights on coverage, eligibility, and how to access these benefits effectively.